Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A comparative study of Humalog Mix25 versus Humalog Mix50

Trial Profile

A comparative study of Humalog Mix25 versus Humalog Mix50

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2018

At a glance

  • Drugs Insulin neutral protamine lispro/insulin lispro (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Aug 2018 Results of a post-hoc analysis assessing the contribution rates of BHG and PPHG to overall hyperglycemia in the T2DM patients treated with LM25 and LM50, published in the Diabetes Therapy
    • 01 Apr 2018 Results published in the Diabetes Therapy
    • 12 Mar 2018 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top